11.66
前日終値:
$11.82
開ける:
$11.81
24時間の取引高:
2.64M
Relative Volume:
0.99
時価総額:
$2.03B
収益:
$61.10M
当期純損益:
$-138.36M
株価収益率:
-8.637
EPS:
-1.35
ネットキャッシュフロー:
$-90.59M
1週間 パフォーマンス:
+1.48%
1か月 パフォーマンス:
-0.26%
6か月 パフォーマンス:
+40.48%
1年 パフォーマンス:
+10.73%
Ocular Therapeutix Inc Stock (OCUL) Company Profile
OCUL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
OCUL
Ocular Therapeutix Inc
|
11.66 | 2.50B | 61.10M | -138.36M | -90.59M | -1.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Ocular Therapeutix Inc Stock (OCUL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-15 | 開始されました | Chardan Capital Markets | Buy |
| 2025-04-08 | 開始されました | William Blair | Outperform |
| 2025-03-18 | 開始されました | RBC Capital Mkts | Outperform |
| 2025-03-11 | 開始されました | Needham | Buy |
| 2024-10-16 | 開始されました | Scotiabank | Sector Outperform |
| 2024-06-20 | アップグレード | TD Cowen | Hold → Buy |
| 2024-05-31 | 再開されました | Piper Sandler | Overweight |
| 2024-02-09 | 開始されました | BofA Securities | Buy |
| 2023-04-21 | 開始されました | Robert W. Baird | Outperform |
| 2022-08-10 | 再開されました | Berenberg | Buy |
| 2021-08-10 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2020-12-28 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2020-12-17 | 開始されました | Berenberg | Buy |
| 2020-11-13 | 繰り返されました | Raymond James | Strong Buy |
| 2020-08-10 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-03-03 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2019-05-21 | ダウングレード | Cowen | Outperform → Market Perform |
| 2019-05-21 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-05-21 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2018-12-03 | 繰り返されました | Cantor Fitzgerald | Overweight |
| 2018-11-15 | 開始されました | Raymond James | Strong Buy |
| 2018-09-07 | 開始されました | Piper Jaffray | Overweight |
| 2017-10-24 | 開始されました | Guggenheim | Buy |
| 2017-07-26 | 開始されました | H.C. Wainwright | Buy |
| 2017-07-12 | 繰り返されました | Cantor Fitzgerald | Overweight |
| 2017-06-23 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2017-02-10 | 開始されました | Cantor Fitzgerald | Overweight |
| 2016-11-15 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2016-08-11 | 開始されました | JMP Securities | Mkt Outperform |
| 2016-02-17 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2015-10-23 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2015-08-13 | 開始されました | Morgan Stanley | Overweight |
すべてを表示
Ocular Therapeutix Inc (OCUL) 最新ニュース
Multi asset correlation models including Ocular Therapeutix Inc.Market Performance Recap & Weekly Return Optimization Alerts - newser.com
Is Ocular Therapeutix Inc. stock oversold or undervalued2025 Trading Volume Trends & Daily Growth Stock Tips - newser.com
Short interest data insights for Ocular Therapeutix Inc.Trade Performance Summary & Community Verified Watchlist Alerts - newser.com
Will Ocular Therapeutix Inc. stock go up soon2025 Trading Recap & Daily Entry Point Trade Alerts - newser.com
How to recover losses in Ocular Therapeutix Inc. stockJuly 2025 Sector Moves & Community Consensus Trade Alerts - newser.com
Why Ocular Therapeutix Inc. stock appeals to analystsEarnings Performance Report & Weekly Stock Performance Updates - newser.com
Is Ocular Therapeutix Inc. (0OT) stock positioned for digital growth eraWeekly Trade Recap & Daily Risk Controlled Trade Plans - newser.com
Real time scanner hits for Ocular Therapeutix Inc. explained2025 Dividend Review & Community Consensus Trade Alerts - newser.com
Can Ocular Therapeutix Inc. (0OT) stock beat analyst consensusJuly 2025 Update & AI Driven Stock Reports - newser.com
What institutional flow reveals about Ocular Therapeutix Inc.July 2025 Institutional & Verified Short-Term Plans - newser.com
Why analysts upgrade Ocular Therapeutix Inc. stockJuly 2025 PreEarnings & Capital Efficient Trade Techniques - newser.com
Ocular Therapeutix (NASDAQ:OCUL) Price Target Raised to $20.00 - MarketBeat
Ocular Therapeutix (OCUL) Projected to Post Earnings on Tuesday - MarketBeat
How Ocular Therapeutix Inc. (0OT) stock behaves in tightening cyclesQuarterly Profit Report & Fast Entry Momentum Trade Alerts - newser.com
Why Ocular Therapeutix Inc. (0OT) stock is trending on social mediaWeekly Trend Summary & Technical Entry and Exit Alerts - newser.com
Is Ocular Therapeutix Inc. stock a buy in volatile marketsWeekly Profit Recap & Verified Technical Trade Signals - newser.com
Is this a good reentry point in Ocular Therapeutix Inc.Market Volume Summary & Long Hold Capital Preservation Tips - newser.com
Using Ichimoku Cloud for Ocular Therapeutix Inc. technicalsMarket Activity Recap & Free Weekly Chart Analysis and Trade Guides - newser.com
Detecting support and resistance levels for Ocular Therapeutix Inc.Layoff News & Verified Momentum Stock Alerts - newser.com
Can Ocular Therapeutix Inc. hit a new high this monthMarket Growth Summary & Reliable Breakout Stock Forecasts - newser.com
Is Ocular Therapeutix Inc. stock undervalued vs historical averages2025 Trade Ideas & AI Based Buy/Sell Signal Reports - newser.com
How Ocular Therapeutix Inc. (0OT) stock responds to job market shifts - newser.com
Ocular Therapeutix (OCUL): TD Cowen Raises Price Target, Reaffir - GuruFocus
Wall Street Analysts Believe Ocular Therapeutix (OCUL) Could Rally 82.93%: Here's is How to Trade - sharewise.com
Ocular Therapeutix Inc (OCUL) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):